Delivery Order SPE2DB22D2108-SPE2DB24FU4GD
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,742.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a completion date of April 26, 2024. This award is part of Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, under which the company provides a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,472.66 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4565470089 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $3,937.95 to provide XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen Drug Corp to...
This is a $2,444.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a period of performance through July 1, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,440.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a completion date of April 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,748.66 to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product, with a completion date of February 6, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA,...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,547.20 firm-fixed-price delivery order is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a completion date of May 17, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $1,705.35 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
This is a $1,565.06 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,937,659 units of the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a ceiling value of $1,436.41 and a completion date of March 13, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen Drug...